Onconova Therapeutics Files for $150 Million Mixed Shelf Offering - (Fidelity via NewsPoints Desk)

  • Onconova Therapeutics filed a registration statement covering the potential sale of up to $150 million in securities, which can be offered from time to time, as reported in Fidelity.

  • Proceeds from the transaction will be used to fund clinical and pre-clinical programs, for R&D activities, and for general corporate purposes, the company said.

To read more NewsPoints articles, click here.